Medicovestor
Pre-clinicalBreakthrough antibody-drug conjugate technology with enhanced immune activation for pancreatic and ovarian cancer treatment.
Founded
2018
Focus
AntibodiesBiologics
About
Breakthrough antibody-drug conjugate technology with enhanced immune activation for pancreatic and ovarian cancer treatment.
Company Info
TypePrivate
Founded2018
LocationNew York, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile